Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
1.00 credit
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d
ADHD After 25 Years: What Have We Learned?
ADHD After 25 Years: What Have We Learned?
NeuroFrontiers
ADHD After 25 Years: What Have We Learned?
James Swanson, PhD
- James Swanson, PhD
What’s Still Missing in ADHD Care?
What’s Still Missing in ADHD Care?
NeuroFrontiers
What’s Still Missing in ADHD Care?
James Swanson, PhD
- James Swanson, PhD
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
NeuroFrontiers
Untangling ADHD from Depression, Anxiety, and Substance Use Disorder
Jill RachBeisel, MD
- Jill RachBeisel, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast Replay
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
1.00 credit
- Dani Cabral, MD
- David Weisman, MD
1.00 credit
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits

Medical News

Medical News
Parkinson's AI Chatbot Misses Critical Safety Errors
10/01/2026
Read more
Medical News
Japanese Study Reveals Treatment‐Resistant Schizophrenia Prevalence in Inpatients
09/29/2026
Read more
Medical News
MRgFUS Thalamotomy Improves Parkinson Tremor at 6 Months
09/23/2026
Read more
Medical News
Childhood-Onset Epilepsy Linked to Lower Educational Attainment
09/16/2026
Read more

CME/CE

The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
Navigating the Limitations of Current BD Therapies
Navigating the Limitations of Current BD Therapies
MinuteCE®
Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 credits 5 episodes
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 credits 5 episodes
Borderline Biomarkers: When a Blood Test Is Not Enough
Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®
Borderline Biomarkers: When a Blood Test Is Not Enough
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits

Clinical Practice

Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
AudioAbstracts
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
- Ryan Quigley
More Than a Myopathy: The Lived Experience of TK2d
More Than a Myopathy: The Lived Experience of TK2d
NeuroFrontiers
More Than a Myopathy: The Lived Experience of TK2d
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiers
ADHD Is Linked to a Broad Burden of GI Symptoms
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
NeuroFrontiers
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class

Programs

Diagnosing Adult ADHD in the Social Media Era
Diagnosing Adult ADHD in the Social Media Era
NeuroFrontiers
Diagnosing Adult ADHD in the Social Media Era
Jill RachBeisel, MD
- Jill RachBeisel, MD
Talking Through Benefits, Risks, and Patient Priorities
Talking Through Benefits, Risks, and Patient Priorities
MinuteCE®
Talking Through Benefits, Risks, and Patient Priorities
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits
MinuteCE®
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD; David Weisman, MD
0.50 credits 6 episodes
- Dani Cabral, MD
- David Weisman, MD
0.50 credits 6 episodes
Antithrombotics and Amyloid Therapy: Balancing Risk
Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®
Antithrombotics and Amyloid Therapy: Balancing Risk
Dani Cabral, MD; David Weisman, MD
0.50 program credits
- Dani Cabral, MD
- David Weisman, MD
0.50 program credits